What is the proposed functional EHRA categorization in relation to the type of oral anticoagulation use in patients with AF?
In keeping with a recent European consensus document, with endorsement by international learned societies, the proposed functional EHRA categorization is a system in relation to the type of oral anticoagulation (OAC) use in patients with AF. This classi cation would have the advantage that it may easily evolve or be updated (type 1 may become type 2 or vice versa) when there are new results. For example, transcatheter mitral valve interventions (eg, to include both MitraClip and Mitral valve replacement) are emerging as a possible but more data are awaited, especially in relation to OAC use.